BackRapid Micro Biosystems Overview

Rapid Micro Biosystems Total Current Liabilities

Track Rapid Micro Biosystems's total current liabilities ($19M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$19.12M
27.49% YoYΔ $4.12M vs prior year quarter

Peer average

Loading

Rapid Micro Biosystems Total Current Liabilities History

Loading

Rapid Micro Biosystems vs. peers: Total Current Liabilities Comparison

Loading

Rapid Micro Biosystems Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Rapid Micro Biosystems (RPID) FAQ

Rapid Micro Biosystems (RPID) currently reports a total current liabilities of $19M as of March 2026. That compares with $15M in the prior-year period — up 27.5% year over year. Use the charts on this page to explore Rapid Micro Biosystems's total current liabilities history and peer comparisons.

Rapid Micro Biosystems's total current liabilities increased from $15M to $19M — a 27.5% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Rapid Micro Biosystems reported $19M in total current liabilities as of March 2026. That compares with $15M in the prior-year period — up 27.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $19M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Rapid Micro Biosystems, and consider following RPID for alerts when major investors trade the stock.

Rapid Micro Biosystems is classified in the Healthcare sector. On total current liabilities, it currently shows $19M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RPID with unrelated industries.